Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe de Moerloose

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Revue Medicale Suisse|March 15, 2014
[Oral anticoagulants and directly observed therapy: the necessity of continuous education]Philippe de Moerloose
Seminars in Thrombosis and Hemostasis|May 28, 2016
The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated DisordersTon Lisman, Philippe de Moerloose
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 1, 2003
Two new antithrombotic agents (fondaparinux and ximelagatran) and their implications in anesthesiaPhilippe de Moerloose, Françoise Boehlen
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 12, 2019
Fibrinogen concentrates in hereditary fibrinogen disorders: Past, present and futureAlessandro Casini, Philippe de Moerloose
Revue Medicale De La Suisse Romande|March 13, 2002
[Two new very promising antithrombotic agents: pentasaccharide and ximelagatran]Stefano Regazzoni, Philippe de Moerloose
Blood|April 25, 2021
How I treat dysfibrinogenemiaAlessandro Casini, Philippe de Moerloose
La Revue Du Praticien|April 4, 2003
[Thrombophilias]Philippe de Moerloose, Françoise Boehlen
Thrombosis Research|October 28, 2004
Anti-beta2-glycoprotein I antibodies--when and how should they be measured?Guido Reber, Philippe de Moerloose
Seminars in Hematology|April 17, 2007
Inherited thrombophilia in arterial disease: a selective reviewPhilippe de Moerloose, Françoise Boehlen
Hamostaseologie|May 27, 2025
Management of Young and Ageing Women with Afibrinogenemia and HypofibrinogenemiaAlessandro Casini, Philippe de Moerloose
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Revue Medicale Suisse|March 15, 2014
[Oral anticoagulants and directly observed therapy: the necessity of continuous education]Philippe de Moerloose
Seminars in Thrombosis and Hemostasis|May 28, 2016
The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated DisordersTon Lisman, Philippe de Moerloose
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 1, 2003
Two new antithrombotic agents (fondaparinux and ximelagatran) and their implications in anesthesiaPhilippe de Moerloose, Françoise Boehlen
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 12, 2019
Fibrinogen concentrates in hereditary fibrinogen disorders: Past, present and futureAlessandro Casini, Philippe de Moerloose
Revue Medicale De La Suisse Romande|March 13, 2002
[Two new very promising antithrombotic agents: pentasaccharide and ximelagatran]Stefano Regazzoni, Philippe de Moerloose
Blood|April 25, 2021
How I treat dysfibrinogenemiaAlessandro Casini, Philippe de Moerloose
La Revue Du Praticien|April 4, 2003
[Thrombophilias]Philippe de Moerloose, Françoise Boehlen
Thrombosis Research|October 28, 2004
Anti-beta2-glycoprotein I antibodies--when and how should they be measured?Guido Reber, Philippe de Moerloose
Seminars in Hematology|April 17, 2007
Inherited thrombophilia in arterial disease: a selective reviewPhilippe de Moerloose, Françoise Boehlen
Hamostaseologie|May 27, 2025
Management of Young and Ageing Women with Afibrinogenemia and HypofibrinogenemiaAlessandro Casini, Philippe de Moerloose
Pageof 14